Commit Biologics ApS
Key figures
- Return on assets
- -101.7%
- Return on equity
- -89.1%
- Current ratio
- 4,008.1%
- Equity ratio
- 97.7%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | -23,365,247 |
Operating profit | -39,469,333 |
Finance income | 204,611 |
Finance expenses | 16,357 |
Tax expense | -5,500,000 |
Profit/loss for the year | -33,781,079 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 17 |
Personnel costs | 15,848,556 DKK |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 30,390,348 |
Current assets | 36,468,996 |
Non-current assets | 2,338,921 |
Total assets | 38,807,917 |
Equity | 37,898,027 |
Liabilities | 909,890 |
Current liabilities | 909,890 |
Working capital
| Reporting period | |
|---|---|
Other current receivables | 519,527 |
Trade payables | 892,957 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 177,413 |
Retained earnings | 37,720,614 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 56,256 |
Property, plant and equipment | 2,282,665 |
Annual report highlights
Business and development
Description of key activities of the companyThe company's object is manufacture of pharmaceutical preparations, research and experimental
development within biotechnology.
Significant changes in the company's activities and financial mattersThere have been no significant changes in activities and financial matters.
The gross loss for the year totals DKK -23.365.247 against DKK -31.408.009 last year. Loss from ordinary activities after tax totals DKK -33.781.079 against DKK -39.360.775 last year. Management considers the net loss for the year expected.…
Risks and material matters
Events occurring after the end of the financial yearFollowing the close of the financial year, the company completed a capital increase, raising DKK 32 million to support planned activities and growth initiatives in 2026.
Commitments and security
2.Contractual obligations and contingencies, etc.
Contingent assetsThe company has a tax loss for carryforward of a total amount of t.dk 50.404. Asset value of the tax loss for carryforward amounts to t.dk. 11.089.…
Create a free account to see up to 9 years of financial history
Create free account